Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.

ABSTRACT:

SUBMITTER: Todo T 

PROVIDER: S-EPMC12003165 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature